Note sull'episodio
What if the next breakthrough in mental health isn’t a molecule—but a mindset?
In this episode of Neural Compass, PsyMed Ventures co-founders Greg Kubin and Matias Serebrinsky join Jimini’s Mark Jacobstein to trace their journey from tech founders to frontier investors betting on the brain. They share how personal experiences with therapy and psychedelics reshaped their view of healing, and why the future of mental health may depend on tools that don’t just treat illness—but expand human potential.
They cover:
- How psychedelics opened the door to a new kind of neuroscience investing
- Why the “century of the brain” will blur the lines between treatment and enhancement
- The business and ethical challenges of funding radical innovation
- What flourishing—not just recovery—could look like in the decades ahead
Parole chiave
AI in mental healthNeuroscience and AIMental health